Literature DB >> 970747

A comparison of pulmonary function in male smokers and nonsmokers.

M Tockman, H Menkes, B Cohen, S Permutt, J Benjamin, W C Ball, J Tonascia.   

Abstract

Results of certain tests of pulmonary function, including a questionnaire, single-breath N2 test of closing capacity, forced expiration, and diffusing capacity were significantly different in groups of male smokers and nonsmokers. The influence of age on these smoking-related changes of pulmonary function was evaluated. The analyses indicated that (1) some tests including number of symptoms; closing capacity, i.e., closing volume plus residual volume as a percentage of total lung capacity; residual volume as a percentage of total lung capacity; Phase III of the single-breath N2 test, and steady-state diffusing capacity (ml of CO/mm Hg - min) revealed significant differences between adjusted mean smoker and nonsmoker values but did not reveal differences associated with age. (2) Tests of forced expiration (1-sec forced expiratory volume/vital capapity, reciprocal of the maximal mid-expiratory flow, maximal flow at 50 per cent of vital capacity; and moments) however, revealed differences between smoker and nonsmoker means )adjusted and unadjusted), as well as increasing smoker-nonsmoker differences with increasing age. It is suggested that the first group of tests probably measured an all-or-none response that occurred with the onset of smoking and was not affected by duration of smoking. The second group of tests probably measured the effects of continued smoking and indicated increasing abnormality associated with longer exposure (years of smoking). Test showing age-related differences between smokers and nonsmokers may reflect cummulative, irreversible changes in pulmonary function to a greater extent than test that do not.

Mesh:

Year:  1976        PMID: 970747     DOI: 10.1164/arrd.1976.114.4.711

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  14 in total

1.  Effects of the multiple risk factor intervention trial smoking cessation program on pulmonary function. A randomized controlled trial.

Authors:  W S Browner; A G Du Chene; S B Hulley
Journal:  West J Med       Date:  1992-11

2.  The smoker's paradox and the real risk of smoking.

Authors:  Friedebert Kunz; Christoph Pechlaner; Helmut Hörtnagl; Rudolf Pfister
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

3.  Changes in arterial oxygen saturation in cigarette smokers following general anaesthesia.

Authors:  A R Tait; J V Kyff; B Crider; V Santibhavank; D Learned; J S Finch
Journal:  Can J Anaesth       Date:  1990-05       Impact factor: 5.063

Review 4.  Assessment of changes in airway calibre I. Tests of forced expiration.

Authors:  N B Pride
Journal:  Br J Clin Pharmacol       Date:  1979-09       Impact factor: 4.335

5.  Passive expiration as a test of lung function.

Authors:  K Ashutosh; J F Keighley
Journal:  Thorax       Date:  1978-12       Impact factor: 9.139

Review 6.  Observations on the pathogenesis of chronic airflow obstruction in smokers: implications for the detection of "early" lung disease.

Authors:  I A Greaves; H J Colebatch
Journal:  Thorax       Date:  1986-02       Impact factor: 9.139

7.  Pre-employment lung function at age 16 years as a guide to lung function in adult life.

Authors:  D J Chinn; J E Cotes; M Fechner; C Elliott
Journal:  Br J Ind Med       Date:  1993-05

8.  Role of radio-aerosol and perfusion lung imaging in early detection of chronic obstructive lung disease.

Authors:  A Garg; P G Gopinath; J N Pande; J S Guleria
Journal:  Eur J Nucl Med       Date:  1983

9.  Influence of smoking habits on change in carbon monoxide transfer factor over 10 years in middle aged men.

Authors:  A Watson; H Joyce; L Hopper; N B Pride
Journal:  Thorax       Date:  1993-02       Impact factor: 9.139

10.  Total effective time of the forced expirogram in disease: sources of error and a correction factor.

Authors:  J Jordanoglou; C Hadjistavrou; G Tatsis; E Anevlavis; C Melissinos
Journal:  Thorax       Date:  1982-04       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.